Welcome to LookChem.com Sign In|Join Free

CAS

  • or
1-benzyl-4-phenylpiperidine-4-carboxylic acid is a piperidine derivative featuring a benzyl and phenyl group attached to the piperidine ring, along with a carboxylic acid group. This chemical compound has been investigated for its potential pharmacological properties, particularly in medicinal chemistry. Its unique structure suggests possible applications in the development of pharmaceuticals, especially for neurological disorders and pain management.

61886-17-7

Post Buying Request

61886-17-7 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

61886-17-7 Usage

Uses

Used in Pharmaceutical Development:
1-benzyl-4-phenylpiperidine-4-carboxylic acid is utilized as a key intermediate in the synthesis of various pharmaceuticals due to its potential pharmacological properties. Its structure allows for the development of compounds that may target neurological disorders and pain management, offering new therapeutic options for patients.
Used in Medicinal Chemistry Research:
As a member of the piperidine derivatives family, 1-benzyl-4-phenylpiperidine-4-carboxylic acid serves as a valuable compound in medicinal chemistry research. Scientists explore its interactions with biological targets and evaluate its efficacy and safety in treating specific conditions, contributing to the advancement of drug discovery and development.

Check Digit Verification of cas no

The CAS Registry Mumber 61886-17-7 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 6,1,8,8 and 6 respectively; the second part has 2 digits, 1 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 61886-17:
(7*6)+(6*1)+(5*8)+(4*8)+(3*6)+(2*1)+(1*7)=147
147 % 10 = 7
So 61886-17-7 is a valid CAS Registry Number.
InChI:InChI=1/C19H21NO2/c21-18(22)19(17-9-5-2-6-10-17)11-13-20(14-12-19)15-16-7-3-1-4-8-16/h1-10H,11-15H2,(H,21,22)

61886-17-7SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 15, 2017

Revision Date: Aug 15, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-benzyl-4-phenylpiperidine-4-carboxylic acid

1.2 Other means of identification

Product number -
Other names 1-Benzyl-4-phenyl-piperidin-4-carbonsaeure

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:61886-17-7 SDS

61886-17-7Relevant articles and documents

Design and synthesis of a new class of malonyl-CoA decarboxylase inhibitors with anti-obesity and anti-diabetic activities

Tang, Haifeng,Yan, Yan,Feng, Zhe,De Jesus, Reynalda K.,Yang, Lihu,Levorse, Dorothy A.,Owens, Karen A.,Akiyama, Taro E.,Bergeron, Raynald,Castriota, Gino A.,Doebber, Thomas W.,Ellsworth, Kenneth P.,Lassman, Michael E.,Li, Cai,Wu, Margaret S.,Zhang, Bei B.,Chapman, Kevin T.,Mills, Sander G.,Berger, Joel P.,Pasternak, Alexander

scheme or table, p. 6088 - 6092 (2010/11/18)

A new series of thiazole-substituted 1,1,1,3,3,3-hexafluoro-2-propanols were prepared and evaluated as malonyl-CoA decarboxylase (MCD) inhibitors. Key analogs caused dose-dependent decreases in food intake and body weight in obese mice. Acute treatment with these compounds also led to a drop in elevated blood glucose in a murine model of type II diabetes.

Compounds with analgesic and local anaesthetic effect

-

, (2008/06/13)

New compounds of the formula (A) STR1 a process for their preparation and their use in the manufacture of pharmaceutical preparations. The new compounds have both local anaesthetic and analgesic effect.

Compounds with analgesic and local anaesthetic effect

-

, (2008/06/13)

New compounds of the formula (A) STR1 a process for their preparation and their use in the manufacture of pharmaceutical preparations. The new compounds have both local anaesthetic and analgesic effect.

1-AZONIABICYCLO[2.2.1]HEPTANES, METHODS OF PREPARING THEM AND PHARMACEUTICAL COMPOSITIONS IN WHICH THEY ARE PRESENT

-

, (2008/06/13)

The invention relates to quaternary basic amides of the formula STR1 in which Ar is an optionally substituted mono-, di-or tricyclic aromatic or heteroaromatic group;T is a direct bond, a hydroxymethylene group, an alkoxymethylene group in which the alkoxy group is C 1-C. sub.4, or a C 1-C 5-alkylene group; Ar' is an unsubstituted or mono-or poly-substituted phenyl, a thienyl, a benzothienyl, a naphthyl or an indolyl; R is hydrogen or a C 1-C. sub.4-alkyl, or a C 1-C 4-ω-alkoxy(C 2-C 4) alkyl, or a C 2-C 4-ω-alkanoyloxy (C 1-C 4)alkyl;.Q is hydrogen;or else Q and R together form a 1,2-ethylene, 1,3-propylene or 1,4-butylene group;Am ⊕ is the radical STR2 in which X 1, X 2 and X 3, together with the nitrogen atom to which they are bonded, form a 1-AZONIABICYCLO[2.2.1] HEPTANE optionally substituted by a phenyl or benzyl group; and A . crclbar. is a pharmaceutically acceptable anion. These compounds are useful for the preparation of drugs intended for the treatment of pathological conditions involving the tachykinin system.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 61886-17-7